Upper gastrointestinal symptoms in obese patients and their outcomes after bariatric surgery.
Obesity is considered an important risk factor for the development of gastrointestinal (GI) disorders, likely through alterations of GI motility. Even though gastroesophageal reflux disease is the condition mainly studied at present, the prevalence of other upper GI symptoms is also augmented in obese patients. Owing to their chronic trend, these disorders have a bearing on public spending and their correct diagnosis would avoid unnecessary cost-consuming investigations. Furthermore, bariatric surgery dramatically changes GI anatomy and physiology, influencing GI symptom outcomes. The aim of this review is to categorize the available results in a pathophysiological framework in an attempt to set up the correct clinical GI management of obese patients before and after bariatric surgery. This would be helpful in tentatively reducing their considerable economic burden on public health services.
Department of Internal Medicine & Medical Specialties, University Sapienza of Rome, Rome, Italy. mcarabotti@yahoo.it
Marilia
M
Carabotti
Carola
C
Severi
Frida
F
Leonetti
Francesco
F
De Angelis
Olga
O
Iorio
Enrico
E
Corazziari
Gianfranco
G
Silecchia
D000273:Adipose Tissue / Q000503:physiopathology; D050110:Bariatric Surgery; D015154:Esophageal Motility Disorders / Q000453:epidemiology; D005743:Gastrectomy; D015390:Gastric Bypass; D005764:Gastroesophageal Reflux / Q000453:epidemiology / Q000503:physiopathology; D005767:Gastrointestinal Diseases / Q000453:epidemiology* / Q000503:physiopathology; D005769:Gastrointestinal Motility; D015391:Gastroplasty; D006356:Heartburn / Q000503:physiopathology; D006801:Humans; D009765:Obesity / Q000453:epidemiology*; D011184:Postoperative Period; D012307:Risk Factors; D041742:Upper Gastrointestinal Tract / Q000503:physiopathology